ADVERSE EVENTS ASSOCIATED WITH ENZYME REPLACEMENT THERAPIES LYSOSOMAL GLYCOGEN-SPECIFIC ENZYME (GAA) MEDICATIONS FOR THE TREATMENT OF POMPE DISEASE

被引：0
|
作者：
Halloush, S. [1 ]
Guo, J. J. [1 ]
机构：
[1] Univ Cincinnati, James L Winkle Coll Pharm, Cincinnati, OH USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EPH139
引用
收藏
页码：S178 / S179
页数：2
相关论文
共 50 条
  • [1] Glycogen response to enzyme replacement therapy in patients with Pompe disease
    Stemmerik, M.
    Vissing, J.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [2] Antibody-mediated enzyme replacement therapy targeting both lysosomal and cytoplasmic glycogen in Pompe disease
    Haiqing Yi
    Tao Sun
    Dustin Armstrong
    Scott Borneman
    Chunyu Yang
    Stephanie Austin
    Priya S. Kishnani
    Baodong Sun
    Journal of Molecular Medicine, 2017, 95 : 513 - 521
  • [3] Antibody-mediated enzyme replacement therapy targeting both lysosomal and cytoplasmic glycogen in Pompe disease
    Yi, Haiqing
    Sun, Tao
    Armstrong, Dustin
    Borneman, Scott
    Yang, Chunyu
    Austin, Stephanie
    Kishnani, Priya S.
    Sun, Baodong
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2017, 95 (05): : 513 - 521
  • [4] Enzyme replacement therapy for the treatment of Pompe disease
    Angelini, Corrado
    EXPERT OPINION ON ORPHAN DRUGS, 2018, 6 (05): : 311 - 318
  • [5] Pregnancy and associated events in women receiving enzyme replacement therapy for late-onset glycogen storage disease type II (Pompe disease)
    Rohman, Philippa J.
    Scott, Elaine
    Richfield, Linda
    Ramaswami, Uma
    Hughes, Derralynn A.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2016, 42 (10) : 1263 - 1271
  • [6] Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy
    van der Beek, N. A. M. E.
    Hagemans, M. L. C.
    van der Ploeg, A. T.
    Reuser, A. J. J.
    van Doorn, P. A.
    ACTA NEUROLOGICA BELGICA, 2006, 106 (02) : 82 - 86
  • [7] Glycogen storage disease type II (Pompe disease) - influence of enzyme replacement therapy in adults
    Merk, T.
    Wibmer, T.
    Schumann, C.
    Krueger, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (02) : 274 - 277
  • [8] Reduced glycogen storage in lymphocytes in patients with Pompe disease following enzyme replacement therapy
    Van Oudheusden, L. J.
    ACTA PAEDIATRICA, 2008, 97 : 121 - 122
  • [9] Delayed infusion reactions associated with enzyme replacement therapies for lysosomal storage disorders
    Utz, Jeanine
    Doyen, Colleen
    Whitley, Chester B.
    MOLECULAR GENETICS AND METABOLISM, 2008, 93 (02) : S40 - S40
  • [10] Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy
    Deniz Güngör
    Juna M de Vries
    Wim CJ Hop
    Arnold JJ Reuser
    Pieter A van Doorn
    Ans T van der Ploeg
    Marloes LC Hagemans
    Orphanet Journal of Rare Diseases, 6
12345